Literature DB >> 10435632

IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.

S Dumon1, S C Santos, F Debierre-Grockiego, V Gouilleux-Gruart, L Cocault, C Boucheron, P Mollat, S Gisselbrecht, F Gouilleux.   

Abstract

Activation of the Jak/STAT pathway by cytokines has been shown to regulate differentiation, proliferation or apoptosis in hematopoeitic cells. Among the Stat proteins, STAT5 is activated by a broad range of cytokines. In order to study the role of STAT5 in hematopoietic cells, we stably expressed a dominant negative form of STAT5 (STAT5A delta749) in the IL-3 dependent bone marrow derived Ba/F3 cell line. Ba/F3 cells expressing STAT5A delta749 were found to be more sensitive to apoptosis than parental or control Ba/F3 cells after IL-3 withdrawal. Analysis of the expression of the cell death regulators, Bcl-2 and Bcl-x, revealed that the level of Bcl-x was lower in Ba/F3 cells expressing STAT5A delta749 than in control cells. IL-3 regulation of Bcl-x expression at protein and mRNA levels was impaired in these cells while that of Bcl-2 expression was unaffected. We further demonstrated that the Bcl-x gene promoter contained a proximal STAT consensus sequence that bound STAT5. Transactivation of a Bcl-x gene promoter reporter construct by STAT5 was observed in Ba/F3 cells. Introduction of a mutation in the STAT binding site abolished this transactivation. These data indicate that Bcl-x is probably a STAT5 target gene. They also support the involvement of STAT5 in hematopoietic cell survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435632     DOI: 10.1038/sj.onc.1202796

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

Review 1.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

2.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 3.  Cytokine-mediated cell survival.

Authors:  Toshiya Inaba
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

4.  Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.

Authors:  Xiaonan Han; Shila Gilbert; Katherine Groschwitz; Simon Hogan; Ingrid Jurickova; Bruce Trapnell; Charles Samson; Jonathan Gully
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

Review 5.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

6.  Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors.

Authors:  T Shinjyo; R Kuribara; T Inukai; H Hosoi; T Kinoshita; A Miyajima; P J Houghton; A T Look; K Ozawa; T Inaba
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 7.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

8.  Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Authors:  Suhu Liu; Sarah R Walker; Erik A Nelson; Robert Cerulli; Michael Xiang; Patricia A Toniolo; Jun Qi; Richard M Stone; Martha Wadleigh; James E Bradner; David A Frank
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma.

Authors:  Natini Jinawath; Chanont Vasoontara; Artit Jinawath; Xueping Fang; Kejia Zhao; Kai-Lee Yap; Tong Guo; Cheng S Lee; Weijie Wang; Brian M Balgley; Ben Davidson; Tian-Li Wang; Ie-Ming Shih
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

10.  Expression and function of bcl-2 proteins in melanoma.

Authors:  Jürgen Eberle; Amir M Hossini
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.